Meeting Banner
Abstract #0587

Significant Reduction of Grey Matter Loss with Vitamin B Treatment in Cognitively Impaired Elderly

SUMMA25Gwenaelle Douaud1, Helga Refsum2, Celeste de Jager2, Robin Jacoby2, Stephen Smith1, A. David Smith2

1FMRIB Centre, University of Oxford, Oxford, Oxfordshire, United Kingdom; 2OPTIMA, University of Oxford

We investigated the impact of B vitamin treatment on grey matter (GM) loss over a 2 year period on cognitively impaired elderly. Using FSL-VBM, we found significant loss of GM in placebo and vitamin groups. However, the GM loss was significantly smaller over time in the vitamin group compared to the placebo group in regions vulnerable to the Alzheimers disease process and showing marked atrophy in the placebo group. Remarkably, higher levels of plasma homocysteine were associated with significantly increased GM atrophy, but this deleterious effect was compensated for by the B vitamin treatment.

Keywords

actually affected already analyses angular assess atrophy beneficial benefit bilaterally body bottom brain carried cerebellar cerebellum certain clinical cluster cofactors cognitive cognitively combination compensated concentrations considered consistently corrected corresponded corresponds decline deleterious dementia determined discrepancy disease distribution dosage doses duration either elderly enzymes especially establish finally findings focused forming framework fusiform gender general healthy impaired impairment included inconsistent inference inferior initial intervention investigated investigating involved kingdom largely larger linear lingual loss marked matched median meta metabolism middle might mild model moderately nonparametric occipital optima outcomes oxford participants period permutation permutations placebo plasma population positive previously process protocol quality raised reduced reducing reduction regional remains remarkably reported reporting risk robin several significantly slowing smith sonata splitting status substantially substrates sufficient system targeted temporal threshold thresholding treatment trial trials unanswered uncorrected underwent vascular vitamin vitamins volunteers vulnerable whether widespread year years